BRIEF-Arena Pharmaceuticals says has cash and cash equivalents as of June 30 of $130.8 mln
July 11, 2017 at 17:28 PM EDT
* Arena Pharmaceuticals - Cash and cash equivalents as of June 30, 2017 of $130.8 million, which includes about $0.2 million of cash held by beacon discovery Source text: [http://bit.ly/2t1agiY] Further company coverage:
